Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

PBYIPBYI
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in PUMA BIOTECHNOLOGY INC

GOLDMAN SACHS GROUP INC holds 669,156 shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $5.4M as of 2026-Q2. The position was decreased (-0.1% shares). PBYI represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$5.4M

Current Shares

669,156

Total Value Change

+$4.5M

Total Shares Change

+355,059

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
669,156
-0.1%
$5.4M0.0%$8.11
0
2026-Q1
Decreased
669,719
-15.7%
$4.3M0.0%$6.21
0
2025-Q4
Increased
793,962
+238.4%
$4.7M0.0%$6.01
43
2025-Q3
Increased
234,617
+16.1%
$1.2M0.0%$5.05
29
2025-Q2
Decreased
202,029
-31.3%
$692,9600.0%$3.33
0
2025-Q1
Decreased
294,243
-6.3%
$870,9600.0%$3.14
0
2024-Q4
New
314,097
-
$957,9960.0%$3.13
35

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used